Search

Author/Creator Locarnini, S.

2. HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg‐positive chronic hepatitis B patients. Issue 1 (11th October 2017)

Authors:
Wong, D.; Littlejohn, M.; Yuen, L.; Jackson, K.; Mason, H.; Bayliss, J.; Rosenberg, G.; Gaggar, A.; Kitrinos, K.; Subramanian, M.; Marcellin, P.; Buti, M.; Janssen, H. L. A.; Gane, E.; Locarnini, S.; Thompson, A.; Revill, P. A.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 1(2018)
Page Start:
114
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. HBsAg mutations correlated with HCC in vivo affect HBsAg release and favor cell proliferation in vitro. (10th February 2016)

Authors:
Salpini, R.; Surdo, M.; Warner, N.; Cortese, M.F.; Mirabelli, C.; Colledge, D.; Soppe, S.; Saccomandi, P.; Pollicita, M.; Longo, R.; Romano, S.; Cappiello, G.; Spanò, A.; Trimoulet, P.; Fleury, H.; Vecchiet, J.; Iapadre, N.; Barlattani, A.; Bertoli, A.; Mari, T.
Journal:
Digestive and liver disease
Issue:
Volume 48(2016)Supplement 1
Page Start:
e20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Toll‐IL1 receptor‐mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated‐IFN in HBeAg‐positive CHB patients. Issue 3 (5th October 2015)

Authors:
Visvanathan, K.; Lang, T.; Ryan, K.; Wilson, R.; Skinner, N. A.; Thompson, A. J. V.; Ahn, S. H.; Weilert, F.; Abbott, W.; Gane, E.; Colledge, D.; Li, K.; Locarnini, S.; Mansell, A.; Revill, P. A.
Journal:
Journal of viral hepatitis
Issue:
Volume 23:Issue 3(2016)
Page Start:
170
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗